Showing 1 - 10 of 574
This paper offers an integrated view of the relationships between health spending, medical innovation, health status, growth and welfare. Health spending triggers technological progress, which is a potential source of better outcomes in terms of longevity and quality of life, a direct source of...
Persistent link: https://www.econbiz.de/10014047534
We study the role of health care within a continuous time economy of overlapping generations subject to endogenous mortality. The economy consists of two sectors: final goods production and a health care sector, selling medical services to individuals. Individuals demand health care with a view...
Persistent link: https://www.econbiz.de/10011437147
We study medical progress within an economy of overlapping generations subject to endogenous mortality. Individuals demand health care with a view to lowering mortality over their life-cycle. We characterise the individual optimum and the general equilibrium of the economy and study the impact...
Persistent link: https://www.econbiz.de/10011781886
We study the impact of health insurance expansion in the US on health expenditure, longevity growth and welfare in an overlapping generations economy in which individuals purchase health care to lower mortality. We consider three sectors: final goods production; a health care sector, selling...
Persistent link: https://www.econbiz.de/10011813315
Persistent link: https://www.econbiz.de/10011696806
The aim of this research is to develop a model to forecast short term health cost changes. The motivation for producing such a model is to provide local decision makers with a tool to predict short term health care costs in their localities. In order to achieve this objective, we collected data...
Persistent link: https://www.econbiz.de/10013072366
This paper investigates the impact of population aging, driven by medical progress, upon agespecific expenditure on health care. In a model set up in discrete time, individuals at each age may catch a lethal disease which, upon receiving appropriate medical treatment, nevertheless involves a...
Persistent link: https://www.econbiz.de/10010300268
We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is estimated to have increased mean age at death by...
Persistent link: https://www.econbiz.de/10010283600
This paper proposes a comprehensive framework for projecting public heath and long-term care expenditures. Notably, it considers the impact of demographic and non-demographic effects for both health and long-term care. Compared with other studies, the paper extends the demographic drivers by...
Persistent link: https://www.econbiz.de/10013110674
This paper proposes a new set of public health and long-term care expenditure projections until 2060, seven years after a first set of projections was published by the OECD. It disentangles health from longterm care expenditure, as well as the demographic from the non-demographic drivers, and...
Persistent link: https://www.econbiz.de/10009767750